| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 258.11B | 145.87B | 136.38B | 142.29B | 121.56B |
| Gross Profit | 85.48B | 52.49B | 46.80B | 49.31B | 33.40B |
| EBITDA | 74.36B | 32.33B | 32.14B | 35.82B | 18.68B |
| Net Income | 11.67B | 13.06B | 16.61B | 20.68B | 2.19B |
Balance Sheet | |||||
| Total Assets | 1.08T | 1.05T | 428.03B | 423.73B | 417.07B |
| Cash, Cash Equivalents and Short-Term Investments | 61.33B | 92.25B | 57.75B | 67.76B | 67.10B |
| Total Debt | 593.57B | 641.55B | 106.84B | 108.64B | 114.42B |
| Total Liabilities | 828.66B | 807.28B | 188.84B | 192.72B | 199.88B |
| Stockholders Equity | 248.68B | 244.12B | 239.19B | 231.00B | 217.19B |
Cash Flow | |||||
| Free Cash Flow | 9.97B | 6.13B | 2.67B | 17.90B | 13.43B |
| Operating Cash Flow | 41.21B | 24.93B | 13.93B | 25.59B | 20.44B |
| Investing Cash Flow | -20.63B | -500.03B | 2.71B | -15.22B | 2.04B |
| Financing Cash Flow | -46.00B | 509.94B | -11.22B | -14.50B | -17.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥2.31T | 16.42 | 15.67% | 1.94% | 8.60% | 10.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥305.35B | 16.15 | ― | 1.51% | ― | ― | |
53 Neutral | ¥204.76B | 17.40 | 3.83% | 4.02% | 76.95% | -10.67% | |
51 Neutral | ¥49.30B | 17.51 | ― | ― | 6.93% | ― | |
49 Neutral | ¥110.83B | 38.33 | ― | ― | 53.43% | 1.83% | |
48 Neutral | ¥51.91B | -0.23 | -78.01% | ― | 4.03% | -747.77% |